284 related articles for article (PubMed ID: 24314380)
1. Morphologic grading and treatment of facial actinic keratosis.
Zalaudek I; Piana S; Moscarella E; Longo C; Zendri E; Castagnetti F; Pellacani G; Lallas A; Argenziano G
Clin Dermatol; 2014; 32(1):80-7. PubMed ID: 24314380
[TBL] [Abstract][Full Text] [Related]
2. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
3. Topical management of actinic keratosis and field cancerisation.
Stockfleth E
G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
[TBL] [Abstract][Full Text] [Related]
4. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Ulrich M; Alarcon I; Malvehy J; Puig S
Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
[TBL] [Abstract][Full Text] [Related]
5. A new vision of actinic keratosis beyond visible clinical lesions.
Malvehy J
J Eur Acad Dermatol Venereol; 2015 Jan; 29 Suppl 1():3-8. PubMed ID: 25470718
[TBL] [Abstract][Full Text] [Related]
6. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
7. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.
Berman B; Cohen DE; Amini S
Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
9. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.
Zalaudek I; Giacomel J; Schmid K; Bondino S; Rosendahl C; Cavicchini S; Tourlaki A; Gasparini S; Bourne P; Keir J; Kittler H; Eibenschutz L; Catricalà C; Argenziano G
J Am Acad Dermatol; 2012 Apr; 66(4):589-97. PubMed ID: 21839538
[TBL] [Abstract][Full Text] [Related]
10. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
Lee AD; Jorizzo JL
Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
[No Abstract] [Full Text] [Related]
12. Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization.
Rossi A; Garelli V; Pranteda G; Cardone M; Anzalone A; Fortuna MC; Di Nunno D; Mari E; De Vita G; Carlesimo M
J Photochem Photobiol B; 2016 Sep; 162():72-76. PubMed ID: 27344021
[TBL] [Abstract][Full Text] [Related]
13. Treatment considerations in actinic keratosis.
Goldenberg G
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
[TBL] [Abstract][Full Text] [Related]
14. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
Bettencourt MS
J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
[TBL] [Abstract][Full Text] [Related]
15. Actinic keratoses: non-invasive diagnosis for field cancerisation.
Ulrich M; Maltusch A; Röwert-Huber J; González S; Sterry W; Stockfleth E; Astner S
Br J Dermatol; 2007 May; 156 Suppl 3():13-7. PubMed ID: 17488401
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of actinic keratosis.
Berman B; Amini S; Valins W; Block S
Expert Opin Pharmacother; 2009 Dec; 10(18):3015-31. PubMed ID: 19925043
[TBL] [Abstract][Full Text] [Related]
17. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
19. Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses.
Ulrich M; Krueger-Corcoran D; Roewert-Huber J; Sterry W; Stockfleth E; Astner S
Dermatology; 2010; 220(1):15-24. PubMed ID: 19907131
[TBL] [Abstract][Full Text] [Related]
20. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited.
Fernandez Figueras MT
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():5-7. PubMed ID: 28263020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
